These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1507569)

  • 21. Role of ATP-sensitive potassium channels in brain stem circulation during hypotension.
    Toyoda K; Fujii K; Ibayashi S; Kitazono T; Nagao T; Fujishima M
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1342-6. PubMed ID: 9321824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxant effects of cromakalim and ATP depletion in dog and rat mesenteric arteries--species differences.
    Hong KW; Rhim BY; Kim CD; Yoo SE
    Arch Int Pharmacodyn Ther; 1994; 328(1):54-66. PubMed ID: 7893191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
    Sargent CA; Smith MA; Dzwonczyk S; Sleph PG; Grover GJ
    J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
    Ohrnberger CE; Khan SA; Meisheri KD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):25-30. PubMed ID: 8229751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
    Rhim BY; Lee WS; Hong KW
    Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
    [No Abstract]   [Full Text] [Related]  

  • 26. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY; Hong KW
    Arch Int Pharmacodyn Ther; 1994; 328(1):67-81. PubMed ID: 7893192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
    Larach DR; Schuler HG
    J Pharmacol Exp Ther; 1993 Oct; 267(1):72-81. PubMed ID: 8229789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of glibenclamide-sensitive K+ current by nucleotide phosphates in isolated rabbit pulmonary myocytes.
    Clapp LH
    Cardiovasc Res; 1995 Sep; 30(3):460-8. PubMed ID: 7585838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of K+ channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea pig detrusor smooth muscle.
    Grant TL; Zuzack JS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1158-64. PubMed ID: 1722252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers.
    Fabiani ME; Vlahos R; Story DF
    Pharmacol Res; 1996; 33(4-5):261-72. PubMed ID: 8938019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium channel inhibitors attenuate neuromodulatory effects of atrial natriuretic factor in the rabbit isolated vas deferens.
    Kanwal S; Trachte GJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):117-23. PubMed ID: 7507992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats.
    Tanaka Y; Yokoyama T; Kashiwabara T; Fukushima H; Izawa T; Ogawa N
    Gen Pharmacol; 1993 Nov; 24(6):1379-81. PubMed ID: 8112509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of endothelium and hyperpolarization in CGRP-induced vasodilation of rabbit ophthalmic artery.
    Zschauer A; Uusitalo H; Brayden JE
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H359-65. PubMed ID: 1510132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of L-NMMA, cromakalim, and glibenclamide on cerebral blood flow in hypercapnia and hypoxia.
    Reid JM; Davies AG; Ashcroft FM; Paterson DJ
    Am J Physiol; 1995 Sep; 269(3 Pt 2):H916-22. PubMed ID: 7573535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Deoxyglucose-induced vasodilation and hyperpolarization in rat coronary artery are reversed by glibenclamide.
    Conway MA; Nelson MT; Brayden JE
    Am J Physiol; 1994 Apr; 266(4 Pt 2):H1322-6. PubMed ID: 8184909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioids contribute to hypoxia-induced pial artery dilation through activation of ATP-sensitive K+ channels.
    Shankar V; Armstead WM
    Am J Physiol; 1995 Sep; 269(3 Pt 2):H997-1002. PubMed ID: 7573545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glibenclamide does not reverse attenuated vasoreactivity to acute or chronic hypoxia.
    Eichinger MR; Resta TC; Balderrama DS; Herrera GM; Richardson LA; Resta JM; Walker BR
    J Appl Physiol (1985); 1995 Oct; 79(4):1173-80. PubMed ID: 8567559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.